<DOC>
	<DOC>NCT00251966</DOC>
	<brief_summary>The purpose of the study is to evaluate the effect of esomeprazole 20 mg od versus placebo for the prevention of gastric and/or duodenal ulcers in patients taking low-dose ASA.</brief_summary>
	<brief_title>ASTERIX: Low Dose ASA and Nexium</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>A clinical diagnosis of a condition (cardiovascular and/or cerebrovascular protection or other reasons) that requires daily intake of lowdose ASA, 75325 mg, and is expected to continue for the duration of the study (daily is defined as at least 5 days per week). Age &gt;= 60 years. No gastric and/or duodenal ulcer at the baseline endoscopy. H. pylori negative by serology test at screening. Upper GI symptoms Erosive oesophagitis Malignancy</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Prevention of gastroduodenal lesions</keyword>
	<keyword>erosive oesophagitis</keyword>
	<keyword>upper GI symptoms</keyword>
</DOC>